Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health CanadaNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 23, 2018 — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. (“Abba”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”)...Read More
Canada House Wellness Group Continues Strategic Transformation with the Hiring of Alex Kroon and Steven Pearce and Announces Issuance of Stock OptionsNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 20, 2018 — The Board of Directors of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) announced today the hiring of Alex Kroon as Executive Vice-President of the Company and President of the Company’s wholly owned subsidiary Marijuana for Trauma (“MFT”) as well...Read More
Canada House Wellness Group Enters into Exclusive Licensing Agreement with Medicine Man Technologies for Canadian Deployment of its Intellectual Property and Product LinesNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, July 17, 2018 — Canada House Wellness Group Inc. (“Canada House”) or the (“Company”) (CSE:CHV) is pleased to announce that it has entered into, through its wholly owned subsidiary Abba Medix Corp., an exclusive licensing agreement with Medicine Man Technologies Inc....Read More
Canada House Wellness Group Continues Strategic Transformation with Appointment of New Chief Executive Officer and Change to Board of DirectorsNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 01, 2018 — The Board of Directors of Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) announced today that Mr. Chris Churchill-Smith will replace Larry Bortles as the Chief Executive Officer of the Company, effective immediately. When Mr. Bortles joined the...Read More
Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. The Company’s goal is to become a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully integrated cannabis therapy company. For more information please visit our Corporate Overview.
Notice: Cautionary Statements Regarding Forward‐Looking Information. Certain statements within this website and related documents pertaining to the Company constitute “forward‐looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward‐looking statements”. Such “forward‐looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward‐looking statements include, but are not limited to, statements with respect to the anticipated effects of the Acquisition, regulatory changes, timeliness of government approvals for the granting of permits and licenses, including the final approval to resume trading on the CSE, changes in medical marijuana prices, actual operating performance of facilities, competition and other risks affecting the Company in particular and the medical marijuana industry generally, including those set out in the Listing Statement.
The Company assumes no responsibility to update or revise forward‐looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.